Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis

Circulating Spike Protein Detected in Post–COVID-19 mRNA Vaccine Myocarditis

Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Immunogenicity among Chimeric Antigen Receptor T Cell Therapy Recipients - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy

Humoral and cellular responses after a third dose of SARS-CoV-2 BNT162b2 vaccine in patients with lymphoid malignancies

Study of efficacy and longevity of immune response to third and fourth doses of COVID-19 vaccines in patients with cancer: A single arm clinical trial

The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment

Peptides for Vaccine Development

Serologic response following SARS-COV2 vaccination in patients with cancer: a systematic review and meta-analysis, Journal of Hematology & Oncology

Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis

Frontiers Adaptive Immune Responses and Immunity to SARS-CoV-2

Frontiers The presence of senescent peripheral T-cells is negatively correlated to COVID-19 vaccine-induced immunity in cancer patients under 70 years of age